Education
About Us
Working with TipRanks
Follow Us
Aim Immunotech Inc. (AIM)
:AIM
Total Valuation
AIM ImmunoTech has a market cap or net worth of $2.91M. The enterprise value is $11.22M.
Market Cap$2.91M
Enterprise Value$11.22M
Share Statistics
AIM ImmunoTech has 72.29M shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding72.29M
Owened by Insiders4.62%
Owened by Instutions0.19%
Financial Efficiency
AIM ImmunoTech’s return on equity (ROE) is -2.83 and return on invested capital (ROIC) is -291.42%.
Return on Equity (ROE)-283.00%
Return on Assets (ROA)-149.44%
Return on Invested Capital (ROIC)-291.42%
Return on Capital Employed (ROCE)-297.47%
Revenue Per Employee$9,047.619
Profits Per Employee-$1,139,476.19
Employee Count21
Asset Turnover0.01
Inventory Turnover-0.14
Valuation Ratios
The current PE Ratio of AIM ImmunoTech is -0.74. AIM ImmunoTech’s PEG ratio is -0.02.
PE Ratio-0.74
PS Ratio105.81
PB Ratio2.09
Price to Fair Value2.09
Price to FCF-0.98
Price to Operating Cash Flow-1.00
PEG Ratio-0.02
Income Statement
In the last 12 months, AIM ImmunoTech had revenue of $190.00K and earned -$23.93M in profits. Earnings per share was -$0.47.
Revenue$190.00K
Gross Profit$38.00K
Operating Income-$27.91M
Pretax Income-$23.93M
Net Income-$23.93M
EBITDA-24.66M
Earnings Per Share (EPS)-0.47
Cash Flow
In the last 12 months, operating cash flow was -$20.69M and capital expenditures -$635.00K, giving a free cash flow of -$21.33M billion.
Operating Cash Flow-$20.69M
Free Cash Flow-$21.33M
Free Cash Flow per Share-$0.30
Dividends & Yields
AIM ImmunoTech pays an annual dividend of , resulting in a dividend yield of
Dividend Per Share
Dividend Yield
Payout Ratio
Free Cash Flow Yield-102.24%
Earnings Yield-135.51%
Stock Price Statistics
Beta1.57
52-Week Price Change-93.75%
50-Day Moving Average0.12
200-Day Moving Average0.24
Relative Strength Index (RSI)39.56
Average Volume (3m)769.77K
Important Dates
AIM ImmunoTech upcoming earnings date is May 15, 2025, TBA.
Last Earnings DateMar 27, 2025
Next Earnings DateMay 15, 2025
Ex-Dividend Date―
Financial Position
AIM ImmunoTech as a current ratio of 1.68, with Debt / Equity ratio of 0.07
Current Ratio1.68
Quick Ratio1.72
Debt to Market Cap0.00
Net Debt to EBITDA0.15
Interest Coverage Ratio0.00
Taxes
In the past 12 months, AIM ImmunoTech has paid $506.72K in taxes.
Income Tax$506.72K
Effective Tax Rate0.00%
Enterprise Valuation
AIM ImmunoTech EV to EBITDA ratio is -0.53, with an EV/FCF ratio of -0.76.
EV to Sales82.43
EV to EBITDA-0.53
EV to Free Cash Flow-0.76
EV to Operating Cash Flow-0.78
Balance Sheet
AIM ImmunoTech has $7.20M in cash and marketable securities with $3.40M in debt, giving a net cash position of -$3.80M billion.
Cash & Marketable Securities$7.20M
Total Debt$3.40M
Net Cash-$3.80M
Net Cash Per Share-$0.05
Tangible Book Value Per Share$0.16
Margins
Gross margin is 79.21%, with operating margin of -15800.00%, and net profit margin of -14337.62%.
Gross Margin79.21%
Operating Margin-15800.00%
Pretax Margin-14337.62%
Net Profit Margin-14337.62%
EBITDA Margin-15682.18%
EBIT Margin-15800.00%
Analyst Forecast
The average price target for AIM ImmunoTech is $4.50, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$4.50
Price Target Upside11150.00%
Analyst ConsensusModerate Buy
Analyst Count0
Revenue Growth Forecast-15.84%
EPS Growth Forecast47.31%